Keymed Biosciences Inc.

HKEX:2162.HK

37.85 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -203.162-203.16223.48423.484-156.785-156.7852.7272.727-129.405-129.405-1,814.25-1,814.25-391.549-391.549-17.743-17.743
Depreciation & Amortization 21.08221.08213.30613.30610.51810.5187.3767.3765.245.245.2315.2315.2525.2524.2354.235
Deferred Income Tax 00-96.8414.277-61.038-9.424-2.799000000000
Stock Based Compensation 12.19812.1987.8427.84212.68612.68611.59811.5988.6578.65749.75549.7550000
Change In Working Capital 7.7197.719-3.794-3.79443.34543.345-52.244-52.24418.92618.926-13.695-13.69518.96618.966-24.179-24.179
Accounts Receivables -9.395-9.395-4.151-4.151-0.3401.991.99-1.99-1.99000000
Change In Inventory 12.03912.039-17.968-17.968-3.262-3.262-10.789-10.7892.0752.075-6.849-6.849-0.169-0.169-1.601-1.601
Change In Accounts Payables 0021.66205.08700000000000
Other Working Capital 5.0755.07518.32518.32546.60746.607-43.445-43.44518.84118.841-6.847-6.84719.13519.135-22.578-22.578
Other Non Cash Items -9.467-9.467-21.017-21.017-28.041-28.041-52.146-52.14631.63931.6391,730.5841,730.584347.559347.559-2.221-2.221
Operating Cash Flow -171.631-171.63119.82119.821-118.278-118.278-82.689-82.689-64.944-64.944-42.375-42.375-19.773-19.773-39.908-39.908
Investing Activities:
Investments In Property Plant And Equipment -38.657-38.657-124.941-124.941-46.044-46.044-93.367-93.367-78.43-78.43-7.464-7.464-5.502-5.502-4.401-4.401
Acquisitions Net 00-170.32079.14500000000000
Purchases Of Investments 00-705.2680-5,614.49100000000000
Sales Maturities Of Investments 001,503.10505,271.54400000000000
Other Investing Activites 50.60850.608347.091347.091-105.194-105.194-78.189-78.189-919.055-919.055-12.992-12.99252.45252.452-99.083-99.083
Investing Cash Flow 11.95211.952222.15222.15-151.237-151.237-171.556-171.556-997.485-997.485-20.455-20.45546.9546.95-103.484-103.484
Financing Activities:
Debt Repayment 00-218.1720-31.89700000000000
Common Stock Issued 0000-34.23800000000000
Common Stock Repurchased -2.074-2.074-14.377-14.377-6.265-6.265-19.303-19.30300000000
Dividends Paid 0000000000000000
Other Financing Activities 40.10340.10312.41412.414-29.933-29.93351.47151.4711,436.5981,436.598382.591382.591-1.91-1.915.6095.609
Financing Cash Flow 38.02938.029-1.964-1.964-36.198-36.19832.16832.1681,436.5981,436.598382.591382.591-1.91-1.915.6095.609
Other Information:
Effect Of Forex Changes On Cash -10.433-10.43315.55515.55519.66919.66949.84649.846-30.665-30.665-2.661-2.661-7.132-7.1323.0483.048
Net Change In Cash -132.083-132.083524.881255.563-700.459-286.044-172.231-172.231343.505343.505317.1317.118.13618.136-134.735-134.735
Cash At End Of Period -132.083-132.0831,203.094255.563678.213890.1141,176.157-172.231343.5051,177.114833.609317.118.136181.274163.138-134.735